WO2026022657 - NOVEL SUBLINGUAL COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES AND HYPERTENSIVE DISEASES
National phase entry is expected:
Publication Number
WO/2026/022657
Publication Date
29.01.2026
International Application No.
PCT/IB2025/057324
International Filing Date
19.07.2025
Title **
[English]
NOVEL SUBLINGUAL COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES AND HYPERTENSIVE DISEASES
[French]
NOUVELLES COMPOSITIONS SUBLINGUALES POUR LE TRAITEMENT DE MALADIES FIBROTIQUES ET DE MALADIES HYPERTENSIVES
Applicants **
COLOGY BIOSCIENCES PRIVATE LIMITED
KOTHAPALLI, Mohini Sridevi
Inventors
KOTHAPALLI, Mohini Sridevi
Priority Data
202441039773
21.07.2024
IN
202441039776
21.07.2024
IN
202541026154
21.03.2025
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3182 | |
| EPO | Filing, Examination, Granting | 27859 | |
| Japan | Filing, Examination, Granting | 3134 | |
| South Korea | Filing, Examination, Granting | 4205 | |
| USA | Filing, Examination, Granting | 9940 |
Total:
48,320
Contact Us
Abstract[English]
The present invention relates to novel sublingual compositions comprising an anti-fibrotic agent, as well as methods for their preparation. Wherein the composition comprising an anti- fibrotic agent such as pirfenidone or nintedanib and its analogs or pharmaceutically acceptable salts thereof. These novel sublingual compositions are intended for use in the treatment of fibrotic diseases, disorders, or conditions, such as idiopathic pulmonary fibrosis (IPF), and hypertensive diseases, disorders, or conditions such as pulmonary hypertension.[French]
La présente invention concerne de nouvelles compositions sublinguales comprenant un agent anti-fibrotique, ainsi que des procédés pour leur préparation. La composition comprend un agent anti-fibrotique tel que la pirfénidone ou le nintédanib et ses analogues ou sels pharmaceutiquement acceptables Ces nouvelles compositions sublinguales sont destinées à être utilisées dans le traitement de maladies, de troubles ou d'états fibrotiques, tels que la fibrose pulmonaire idiopathique (FPI), et des maladies, des troubles ou des états hypertensifs tels que l'hypertension pulmonaire.